In terms of informed consent, most subjects without professional knowledge cannot accurately understand the principle of gene therapy, so it is difficult to fully understand the risks they assume. Another risk is that many gene therapies treat serious genetic diseases, and therefore often need to be treated when the patient is an infant or infant, when informed consent and choice for gene therapy will be up to the parent or guardian. There is also no clear consensus on whether parents or guardians should be able to select genes for patients that might alter parts of their cells.
emphasized by the passage?
Difficulty in realizing informed consent in gene therapy